Lv11
30 积分 2024-03-29 加入
Risk factors and management strategies associated with non-response to aminosalicylates for maintenance treatment in ulcerative colitis
1小时前
待确认
Sa1675: PLACEBO EFFECTS ACROSS THERAPIES IN DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS
1个月前
已完结
Comparative Efficacy of IL-12/23 and IL-23 Inhibitors for Induction and Maintenance Therapy in Moderate to Severe Crohn’s Disease: A Systematic Review and Network Meta-Analysis
1个月前
已完结
Risankizumab Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomized Phase 3 INSPIRE Study
1个月前
已完结
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study
1个月前
已完结
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis
1个月前
已完结
Comparative Efficacy of IL-12/23 and IL-23 Inhibitors for Induction and Maintenance Therapy in Moderate to Severe Crohn’s Disease: A Systematic Review and Network Meta-Analysis
2个月前
已完结
Large language models for clinical decision support in gastroenterology and hepatology
2个月前
已完结
Emerging trends in multi-modal artificial intelligence for clinical decision support: A narrative review
2个月前
已完结
Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohnʼs disease
3个月前
已完结
皖公网安备34019202002308
